Rapid treatment for PTSD using brain stimulation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the effectiveness of an accelerated transcranial magnetic stimulation (TMS) protocol designed to quickly alleviate symptoms of PTSD over a one-week period, involving 25 treatment sessions. Participants will be randomly assigned to one of three groups: active left dl-PFC TMS, active dm-PFC TMS, or a sham treatment. Following the initial week, all participants will receive active left dl-PFC TMS in a second week, with outcomes assessed over a six-month follow-up period. The primary measure of effectiveness will be the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).

Why it matters

Who can join: the full rules

Inclusion:

1. Adults age 18 years to 65 years old.
2. Meets DSM-5 criteria for PTSD with a PCL-5 score \> 33
3. No changes in psychotropic medication (if taking psychotropic medication) and/or changes in supportive psychotherapy for 1 month prior to initial visit; and clinically appropriate to maintain stable treatment regimen for duration of trial.
4. Clinically competent to give informed written consent and ability to understand study procedures and to comply with them for the entire length of the study

Exclusion:

1. Medical contraindication for neuromodulation (e.g., ferrous metal in head, seizure disorder, brain tumor, stroke, aneurysm, multiple sclerosis, etc.).
2. Active substance use disorder in last 3 months or any current substance use that puts the participant at increased risk or significant impairment.
3. Dementia or other cognitive disorder making unable to engage in treatment.
4. Any history or diagnosis of Schizophrenia, Schizoaffective Disorder, Delusional Disorder or other psychotic illness that precludes safe participation in trial.
5. Suicidal risk that precludes safe participation defined as clinical impression that the participant is at significant risk for suicide.
6. OCD cannot be the primary disorder but can have OCD symptoms.
7. Inability to stop taking any medication that significantly lowers the seizure threshold (e.g., tricyclic antidepressants, clozapine, etc.)
8. Current, planned, or suspected pregnancy
9. Unstable medical conditions or any current medical condition that could preclude being able to safely participate in TMS treatment (e.g., unstable metabolic abnormality, unstable angina, etc.)
10. Severe Traumatic Brain Injury
11. We will exclude non-English speakers because of the need for rapid communication during the delivery of treatments.
12. Significant ongoing litigation or claims that impact research activities, as determined by the research study team. (Research may especially be impacted when mental health or pain is being evaluated for litigation or claims, such as civil and criminal cases, disability claims and worker's compensation).
13. Prior known active TMS of dorsolateral prefrontal cortex or dorsomedial prefrontal cortex or electroconvulsive therapy (ECT) -

Where it's running

• Florida State University
  Tallahassee, Florida, United States Recruiting

Study contacts

• Principal investigator: Frank A Kozel, MD — Florida State University
• Study coordinator: Isabelle M Taylor, MA
• Email: fsun@fsu.edu
• Phone: 850-644-2824

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term outcomes after Hyperbaric Oxygen Therapy in veterans with TBI, PCS, or PTSD

  This study tests whether benefits from HBOT persist over time for veterans with brain injury or related conditions.

  Recruiting Phase 2 Summit Hyperbarics and Wellness · Boise, Idaho · NCT07732374

• Non‑trauma PTSD treatment for veterans and service members with mild or moderate TBI

  This pilot will test a non‑trauma psychotherapy program to help veterans and service members with mild or moderate traumatic brain injury who have PTSD.

  Recruiting The University of Texas Health Science Center at San Antonio · Fort Hood, Texas · NCT07351305

• Improving sleep for Veterans with traumatic brain injury, PTSD, and chronic pain

  We will try morning bright light therapy at home to improve sleep for Veterans who have TBI, PTSD, and chronic pain.

  Recruiting VA Office of Research and Development · Portland, Oregon · NCT06477796

• Enhancing memory through amygdala stimulation

  This study is testing if stimulating a part of the brain called the amygdala can help improve memory in people with epilepsy who are being monitored for seizures.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT05065450

• Using cannabidiol to treat PTSD and traumatic brain injury symptoms

  This study is testing if taking cannabidiol (CBD) can help people with PTSD, some of whom also have mild brain injuries, feel better compared to a placebo.

  Recruiting Phase 2 NYU Langone Health · New York, New York · NCT04550377

• Evaluating retinal imaging for neurodegenerative diseases

  This study is testing if special eye scans can help spot early signs of neurodegenerative diseases like Alzheimer's and Parkinson's in people.

  Recruiting Duke University · Durham, North Carolina · NCT03233646

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.